Cyclerion Therapeutics, Inc.

NasdaqCM:CYCN Stock Report

Market Cap: US$8.3m

Cyclerion Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:CYCN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Nov 24SellUS$555,108Slate Path Capital LPCompany357,880US$1.55

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CYCN?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds334,23713.2%
Institutions386,78315.3%
Individual Insiders593,60323.5%
General Public1,216,27548.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.


Top Shareholders

Top 24 shareholders own 51.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
Peter Hecht
377,385US$1.2m0%no data
6.7%
MFN Partners Management, LP
169,460US$557.5k0%0.01%
6.51%
Tyndall Capital Partners LP
164,777US$542.1k0%100.0%
6.23%
FMR LLC
157,636US$518.6k-2.34%no data
4.59%
Artal Group S.A.
116,155US$382.2k-1.26%0.01%
3.96%
Regina Graul
100,303US$330.0k0%no data
1.98%
Errol De Souza
50,000US$164.5k0%no data
1.43%
Polaris Venture Partners, Inc.
36,121US$118.8k0%0.07%
1.34%
Geode Capital Management, LLC
33,908US$111.6k-0.21%no data
0.93%
The Vanguard Group, Inc.
23,490US$77.3k0%no data
0.79%
Steven Hyman
20,000US$65.8k0%no data
0.79%
Michael Higgins
20,000US$65.8k0%no data
0.79%
Dina Katabi
20,000US$65.8k0%no data
0.66%
BlackRock, Inc.
16,797US$55.3k-2.17%no data
0.23%
Terrance McGuire
5,897US$19.4k0%no data
0.043%
Tower Research Capital Europe Limited
1,078US$3.5k-26.4%no data
0.026%
Morgan Stanley, Investment Banking and Brokerage Investments
649US$2.1k0%no data
0.021%
Group One Trading LP, Asset Management Arm
540US$1.8k0%no data
0.0057%
UBS Asset Management AG
145US$477.1-94.6%no data
0.0055%
Bg Fund Management Luxembourg S.A.
140US$460.50%no data
0.004%
Activest Wealth Management, LLC
100US$328.90%no data
0.00091%
Bank of America Corporation, Asset Management Arm
23US$75.843.8%no data
0.00071%
Rhonda Chicko
18US$59.10%no data
0.00004%
Northwestern Mutual Wealth Management Company
1US$3.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:01
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cyclerion Therapeutics, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pete StavropoulosCantor Fitzgerald & Co.
Martin AusterCredit Suisse
Joon So LeeTruist Securities